Market Cap
$11.39 Billion
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
Thermo Fisher Scientific
|
$222.61 B |
Danaher
|
$164.98 B |
Siemens Healthineers AG
|
$57.84 B |
IDEXX Laboratories, Inc.
|
$53.62 B |
Lonza Group Ltd
|
$47.58 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
Revvity, Inc., formerly part of PerkinElmer, Inc., offers solutions for diagnostics and life sciences markets globally. It provides tools for life science research, environmental analysis, industrial processes, and genomic workflows via two segments: Discovery & Analytical Solutions and Diagnostics. The latter focuses on early disease detection, including genetic disorders. Established in 1937, it serves a broad range of sectors, from pharmaceuticals to academia.
Revvity, Inc. has the following listings and related stock indices.
Stock: NYSE: RVTY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.